Comparison of Amplicor and Genexpert MTB/RIF Tests for diagnosis of Tuberculous meningitis

24Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are no data about the comparative accuracy of commercially available nucleic acid amplification tests (GeneXpert MTB/ RIF and Roche Amplicor) for the diagnosis of tuberculous meningitis (TBM). A total of 148 patients with suspected TBM were evaluated, and cultures served as the reference standard. The sensitivities and specificities (95% confidence interval [CI]) for the Amplicor and Xpert MTB/RIF tests were similar: 46 (31- 60) versus 50 (33- 67) and 99 (93-100) and 94 (84 -99), respectively. Copyright

Cite

CITATION STYLE

APA

Patel, V. B., Connolly, C., Singh, R., Lenders, L., Matinyenya, B., Theron, G., … Dheda, K. (2014). Comparison of Amplicor and Genexpert MTB/RIF Tests for diagnosis of Tuberculous meningitis. Journal of Clinical Microbiology, 52(10), 3777–3780. https://doi.org/10.1128/JCM.01235-14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free